Cellular Biomedicine Group, Inc. 4
4 · Cellular Biomedicine Group, Inc. · Filed Apr 14, 2016
Insider Transaction Report
Form 4
Cao Wei (William)
DirectorPresident and COO
Transactions
- Exercise/Conversion
Common Stock
2016-03-01$5.40/sh+10,000$54,000→ 184,472 total - Sale
Common Stock
2016-03-01$17.15/sh−10,000$171,500→ 174,472 total - Exercise/Conversion
Non- Qualified Stock Option (right to buy) (2013 Plan)
2016-03-01+10,000→ 40,000 totalExercise: $5.40Exp: 2023-09-30→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- [F2]The option vests according to the following schedule: 1/36th per month following the vesting commencement date of September 30, 2013.
- [F3]Due to a delay in communication with regard to the timing of the transactions reported herein, the total number of derivative securities of the issuer beneficially owned by the reporting person reported in his Form 4 filed on March 4, 2016 did not account for the change in derivative securities owned as a result of the transactions reported herein. As of the date of this report, the total number of derivative securities of the issuer beneficially owned by the reporting person under his 2013 non-qualified stock option plan is 32,500.